6 Development of Receptor-Specific Opioid Peptide Analogues
- 1 January 1991
- book chapter
- Published by Elsevier in Progress in Medicinal Chemistry
- Vol. 28, 301-340
- https://doi.org/10.1016/s0079-6468(08)70367-9
Abstract
No abstract availableThis publication has 100 references indexed in Scilit:
- A preliminary study of the pharmacodynamics and pharmacokinetics of a novel enkephalin analogue [Tyr-D.Arg-Gly-Phe(4NO2)·Pro·NH2 (BW443C)] in healthy volunteersEuropean Journal of Clinical Pharmacology, 1988
- Covalent labeling of opioid receptors with 3HDAla2Leu5-enkephalin chloromethyl ketone I. Binding characteristics in rat brain membranesLife Sciences, 1987
- A novel cyclic opioid peptide analog showing high preference for μ-receptorsBiochemical and Biophysical Research Communications, 1985
- Comparison of μ-, δ- and κ-receptor binding sites through pharmacologic evaluation of p-nitrophenylalanine analogs of opioid peptidesLife Sciences, 1983
- Human tolerability studies with D-Met2, Pro5-enkephalinamideLife Sciences, 1983
- Deltakephalin, Tyr-D-Thr-Gly-Phe-Leu-Thr: A new highly potent and fully specific agonist for opiate δ-receptorsBiochemical and Biophysical Research Communications, 1983
- Lysine substitution increases mu-selectivity of potent di- and tri-peptide enkephalin analogsLife Sciences, 1983
- Divergent structure activity relationships in series of enkephalin agonists and cognate antagonistsLife Sciences, 1983
- Cyclic enkephalin analogs containing a cystine bridgeBiochemical and Biophysical Research Communications, 1981
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973